(Q57401905)

Betina Heinsbæk Thuesen

5

0 references

Allan Linneberg

Allan Linneberg

9

0 references

Peter Rossing

Peter Rossing

8

0 references

Torben Jørgensen

Torben Jørgensen

4

0 references

Charlotta Pisinger

3

Charlotta Pisinger

0 references

author name string

Lise Lotte Nystrup Husemoen

2

0 references

Knud Rasmussen

6

0 references

Mogens Fenger

https://scigraph.springernature.com/pub.10.1007/s12020-013-9887-0

7

0 references

publication date

4 February 2013

0 references

published in

Endocrine

0 references

volume

44

0 references

issue

2

0 references

page(s)

473-480

0 references

exact match

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9887-0

2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9887-0

Update on microalbuminuria as a biomarker in renal and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9887-0

Microalbuminuria in relation to the metabolic syndrome and its components in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9887-0

Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9887-0

Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9887-0

Plasma parathyroid hormone and the risk of cardiovascular mortality in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9887-0

Phylloquinone and vitamin D status: associations with incident chronic kidney disease in the Framingham Offspring cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9887-0

A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9887-0

Relative validity of a food frequency questionnaire used in the Inter99 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9887-0

Determinants of vitamin D status in a general population of Danish adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9887-0

Vitamin D status assessed by a validated HPLC method: within and between variation in subjects supplemented with vitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9887-0

Statistics notes: Analysing controlled trials with baseline and follow up measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9887-0

The relation of serum 25-hydroxyvitamin-D levels with severity of obstructive sleep apnea and glucose metabolism abnormalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9887-0

Serum 25(OH)D and type 2 diabetes association in a general population: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9887-0

Serum 25(OH)D and incident type 2 diabetes: a cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9887-0

Effect of interval between serum draw and follow-up period on relative risk of cancer incidence with respect to 25-hydroxyvitamin D level: Implications for meta-analyses and setting vitamin D guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9887-0

First morning voids are more reliable than spot urine samples to assess microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9887-0

Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9887-0

Preanalytical stability of 25(OH)-vitamin D3 in human blood or serum at room temperature: solid as a rock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9887-0

Measurement of Vitamin D metabolites: an international perspective on methodology and clinical interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9887-0

Current assays overestimate 25-hydroxyvitamin D3 and underestimate 25-hydroxyvitamin D2 compared with HPLC: need for assay-specific decision limits and metabolite-specific assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9887-0

Determining vitamin D status: a comparison between commercially available assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9887-0

Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake

21 January 2018

1 reference

12 December 2020

Calcium Metabolism in Early Chronic Renal Failure: Implications for the Pathogenesis of Hyperparathyroidism

1 reference

12 December 2020

Stability of blood (pro)vitamins during four years of storage at −20 °C: Consequences for epidemiologic research

1 reference

12 December 2020

25-Hydroxyvitamin D assays: the quest for accuracy

1 reference

12 December 2020

25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III)

1 reference

12 December 2020

Vitamin D status and incident cardiovascular disease and all-cause mortality: a general population study

1 reference

12 December 2020

K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease

1 reference

12 December 2020

Definition of microalbuminuria in first-morning and random spot urine in diabetic patients

1 reference

12 December 2020

Parathyroid hormone as a marker for the differential diagnosis of acute and chronic renal failure

1 reference

12 December 2020

Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients with left ventricular hypertrophy and diabetes.

1 reference

12 December 2020

Laboratory measurement of urine albumin and urine total protein in screening for proteinuria in chronic kidney disease.

1 reference

12 December 2020

Vitamin D and diabetes mellitus

1 reference

12 December 2020

Obesity: preventing and managing the global epidemic. Report of a WHO consultation

1 reference

12 December 2020